"Our team diagnoses, evaluates and treats patients with autoimmune diseases, arthritis and various musculoskeletal pain disorders."

During the past decade, Kadlec Clinic Rheumatology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kadlec Clinic Rheumatology" are "Psoriatic Arthritis" (2 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Kadlec Clinic Rheumatology" in a lesser frequency.

Most popular intervention types in "Kadlec Clinic Rheumatology" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Baricitinib" (1 trials), "Ixekizumab" (1 trials), "Ixekizumab 80 mg Q2W" (1 trials) and "Ixekizumab 80 mg Q4W" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kadlec Clinic Rheumatology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Kadlec Clinic Rheumatology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Kadlec Clinic Rheumatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kadlec Clinic Rheumatology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".